|
Market Closed -
TEL AVIV STOCK EXCHANGE
15:24:30 08/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 1,060.00 ILa | -1.03% |
|
-5.27% | -3.11% |
| Market Cap | 121M 12.1B 39.55M 35.26M 32.84M 29.89M 56.27M 3.82B 56.84M 394M 154M 1.95B 148M 145M 6.24B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 249M 24.9B 81.39M 72.57M 67.59M 61.5M 116M 7.87B 117M 811M 318M 4.01B 305M 299M 12.83B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.03% | ||
| 1 week | -5.27% | ||
| Current month | -5.27% | ||
| 1 month | -1.85% | ||
| 3 months | -1.40% | ||
| 6 months | -12.47% | ||
| Current year | -3.11% |
| 1 week | 1,050 |  | 1,153 |
| 1 month | 1,044 | | 1,237 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,740 |
| 5 years | 1,006 | | 2,610 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 23/08/1993 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 31/10/2018 |
| President | 80 | 27/06/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 24/06/2010 | |
| Director/Board Member | 80 | - | |
Avraham Bigger
CHM | Chairman | 80 | 14/04/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.03% | -5.27% | -8.78% | -40.42% | 39.82M | |
| -1.61% | +1.08% | +38.64% | +106.93% | 1,060B | |
| -0.76% | -3.12% | +35.78% | +62.70% | 623B | |
| +0.39% | +4.14% | +17.00% | +83.77% | 480B | |
| -0.29% | -2.02% | +62.52% | +37.06% | 352B | |
| -2.03% | +1.03% | +22.25% | +42.16% | 345B | |
| -1.92% | -1.87% | +11.94% | +33.20% | 274B | |
| -2.36% | -3.16% | -6.95% | +8.68% | 249B | |
| -1.37% | -3.34% | +37.86% | +52.33% | 223B | |
| +0.17% | -1.31% | +25.96% | +96.82% | 182B | |
| Average | -1.13% | -0.86% | +23.62% | +48.32% | 378.8B | |
| Weighted average by Cap. | -0.79% | +0.04% | +30.57% | +68.82% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 32.17B 105M 93.75M 87.32M 79.46M 150M 10.17B 151M 1.05B 410M 5.18B 394M 386M 16.58B | 301M 30.1B 98.38M 87.72M 81.7M 74.34M 140M 9.51B 141M 980M 384M 4.85B 369M 361M 15.51B |
| Net income | 6.21M 621M 2.03M 1.81M 1.68M 1.53M 2.89M 196M 2.92M 20.2M 7.91M 99.92M 7.61M 7.44M 320M | -18.07M -1.81B -5.91M -5.27M -4.91M -4.46M -8.41M -571M -8.49M -58.84M -23.05M -291M -22.16M -21.68M -932M |
| Net Debt | 127M 12.71B 41.54M 37.04M 34.49M 31.39M 59.11M 4.02B 59.71M 414M 162M 2.05B 156M 152M 6.55B | 128M 12.8B 41.84M 37.31M 34.75M 31.62M 59.53M 4.05B 60.14M 417M 163M 2.06B 157M 154M 6.6B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/10/26 | ILA 1,060.00 | -1.03% | 1,480 |
| 07/10/26 | ILA 1,071.00 | -2.28% | 152 |
| 06/10/26 | ILA 1,096.00 | +0.46% | 47 |
| 05/10/26 | ILA 1,091.00 | -7.23% | 10,403 |
| 01/10/26 | ILA 1,176.00 | +5.09% | 1,509 |
- Stock Market
- Stocks
- REKA Stock
Select your edition
All financial news and data tailored to specific country editions
